Emergent BioSolutions Inc. Common Stock (NY:EBS)

6.330 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

February 29, 2024

From Emergent BioSolutions

Via GlobeNewswire

What's Going On Emergent BioSolutions Shares Today? ↗

February 22, 2024

Emergent BioSolutions' shares slide in premarket trading today after ending yesterday's run with a whopping 78% jump. The company announced the appointment of Joseph C. Papa as CEO.

Via Benzinga

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today? ↗

February 21, 2024

Investors in Emergent Biosolutions and EBS stock certainly have a big catalyst to cheer today, as the company announced a new CEO.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 21, 2024

Via Benzinga

Emergent BioSolutions Inc. (NYSE: EBS) is One of Wednesday Morning’s Most Active Stocks

February 21, 2024

Via Investor Brand Network

Earnings Preview For Emergent BioSolutions ↗

November 07, 2023

Via Benzinga

Why Emergent BioSolutions Stock Is Tumbling Today ↗

August 22, 2023

The healthcare stock will soon be booted from an index tracked by several ETFs.

Via The Motley Fool

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 21, 2024

Via Benzinga

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

February 21, 2024

From Emergent BioSolutions

Via GlobeNewswire

Contrarian Calls: 7 Analyst ‘Sell’ Ratings That Should Be ‘Buys’ ↗

January 31, 2024

While it’s usually a good idea to trust Wall Street’s top experts, sometimes, it’s worthwhile to consider contrarian analyst picks.

Via InvestorPlace

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

January 11, 2024

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

January 09, 2024

From Emergent BioSolutions

Via GlobeNewswire

Why Is Icosavax (ICVX) Stock Up 46% Today? ↗

December 12, 2023

Icosavax stock is up on Tuesday as investors react to an acquisition deal with AstraZeneca that values ICVX between $15 and $20 per share.

Via InvestorPlace

EBS Stock Earnings: Emergent BioSolutions Misses EPS, Beats Revenue for Q3 2023 ↗

December 12, 2023

EBS stock results show that Emergent BioSolutions missed analyst estimates for earnings per share but beat on revenue for the third quarter of 2023.

Via InvestorPlace

What's Going On With Emergent Biosolutions Stock? ↗

November 28, 2023

Emergent Biosolutions Inc (NYSE: EBS) shares initially traded higher Tuesday before pulling back and turning negative.

Via Benzinga

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

November 28, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing

November 24, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions (EBS) Q3 2023 Earnings Call Transcript ↗

November 08, 2023

EBS earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Emergent BioSolutions Reports Third Quarter 2023 Financial Results

November 08, 2023

From Emergent BioSolutions

Via GlobeNewswire

UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 8, 2023

October 30, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on November 2, 2023

October 19, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors

October 02, 2023

From Emergent BioSolutions

Via GlobeNewswire

Opioid Overdose Treatment: Walgreens To Stock FDA-Approved NARCAN Spray ↗

August 30, 2023

Walgreens Boots Alliance Inc (NASDAQ: WBA) said

Via Benzinga

Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency

August 30, 2023

From Emergent BioSolutions

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2023 ↗

August 29, 2023

Via Benzinga

Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 22, 2023

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.

Via Benzinga

Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarket ↗

August 22, 2023

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares gained 65% to $0.2887 in pre-market trading after gaining 12% on Monday. The company recently posted a narrower-than-expected quarterly loss.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 22, 2023

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers investors will want to keep an eye on!

Via InvestorPlace

PureCycle Technologies, Canadian Solar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

August 22, 2023

U.S. stock futures traded higher this morning on Tuesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.